olopatadine hydrochloride ophthalmic solution
Generic: olopatadine hydrochloride ophthalmic
Labeler: albertsons companiesDrug Facts
Product Profile
Brand Name
olopatadine hydrochloride ophthalmic solution
Generic Name
olopatadine hydrochloride ophthalmic
Labeler
albertsons companies
Dosage Form
SOLUTION
Routes
Active Ingredients
olopatadine hydrochloride 2 mg/mL
Manufacturer
Identifiers & Regulatory
Product NDC
21130-105
Product ID
21130-105_ac0a51c9-185a-9d58-cb21-ee5b6a1134d6
Product Type
HUMAN OTC DRUG
Marketing Category
ANDA
Application Number
ANDA209752
Listing Expiration
2026-12-31
Marketing Start
2021-06-25
Pharmacologic Class
Classes
Normalized Code Variants
Searchable formats for this product NDC code
Digits Only
21130105
Hyphenated Format
21130-105
Supplemental Identifiers
RxCUI
UNII
Resolved Product View
Precedence rule: structured NDC data is preferred, falling back to linked label metadata when unavailable. Source tags show the origin of each value.
Resolved Identity
Brand Name
olopatadine hydrochloride ophthalmic solution (source: ndc)
Generic Name
olopatadine hydrochloride ophthalmic (source: ndc)
Application Number
ANDA209752 (source: ndc)
Routes
source: ndc
Resolved Composition
Strengths
- 2 mg/mL
Packaging
- 1 BOTTLE, PLASTIC in 1 CARTON (21130-105-02) / 2.5 mL in 1 BOTTLE, PLASTIC
Packages (1)
Ingredients (1)
Linked Drug Pages (1)
Raw FDA Data
View complete raw FDA NDC JSON payload
{"route": ["OPHTHALMIC"], "spl_id": "ac0a51c9-185a-9d58-cb21-ee5b6a1134d6", "openfda": {"unii": ["2XG66W44KF"], "rxcui": ["1111343"], "spl_set_id": ["685192af-d729-3066-5825-6d0e03ce787e"], "manufacturer_name": ["Albertsons Companies"]}, "finished": true, "packaging": [{"sample": false, "description": "1 BOTTLE, PLASTIC in 1 CARTON (21130-105-02) / 2.5 mL in 1 BOTTLE, PLASTIC", "package_ndc": "21130-105-02", "marketing_start_date": "20210625"}], "brand_name": "Olopatadine Hydrochloride Ophthalmic Solution", "product_id": "21130-105_ac0a51c9-185a-9d58-cb21-ee5b6a1134d6", "dosage_form": "SOLUTION", "pharm_class": ["Decreased Histamine Release [PE]", "Histamine H1 Receptor Antagonists [MoA]", "Histamine-1 Receptor Antagonist [EPC]", "Histamine-1 Receptor Inhibitor [EPC]", "Mast Cell Stabilizer [EPC]"], "product_ndc": "21130-105", "generic_name": "Olopatadine Hydrochloride Ophthalmic", "labeler_name": "Albertsons Companies", "product_type": "HUMAN OTC DRUG", "brand_name_base": "Olopatadine Hydrochloride Ophthalmic Solution", "active_ingredients": [{"name": "OLOPATADINE HYDROCHLORIDE", "strength": "2 mg/mL"}], "application_number": "ANDA209752", "marketing_category": "ANDA", "marketing_start_date": "20210625", "listing_expiration_date": "20261231"}